TAMPA, Fla.--(BUSINESS WIRE)--Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) today announced the release of an analytical profile on the Company by respected micro-cap analyst Mr. Paul Silver, Director of Research for Wall Street Resources, Inc., which contains a 12-month target value for NNBP of $0.83 per share. The free report is available at: www.wallstreetresources.net/pdf/fc/NNBP2.pdf. The 31-page report includes detailed information on the Company’s business model, products, industry, valuation, management and risks.
